Bracco invests 60 million euros in Geneva

The Italian group is launching the construction of a second production line in Geneva to support the strong growth of its medical imaging product Hexagon.

Bracco is announcing a €60 million investment in Geneva for the construction of a new multifunctional building, which will double the production of its ultrasound contrast product SonoVue / Lumason. The Milan-based group’s Hexagon project has as its strategic objective to boost the Geneva platform, which has been responsible for the production and marketing of its flagship product since 2001.

In 2018, the Bracco Group invested more than €120 million, including 96.5% in its core activity, Imaging, mainly in the industrial sector, to increase production capacity and improve efficiency and manufacturing processes at the Torviscosa and Ceriano Laghetto sites in Italy, as well as at the Geneva site, which should welcome 20 new employees by 2024. About a hundred employees specialized in the field of contrast agents for medical imaging are currently working at the Plan-Les-Ouates site, which has been commercializing its flagship product SonoVue / Lumason since 2001.

In the heart of the Health Valley since 1989

Bracco is an international group active in the healthcare sector and a leader in diagnostic imaging, employing around 3,450 people with an annual turnover of about €1.29 billion. In the field of research and development, the company invests approximately 9% of its turnover in the fields of imaging diagnostics and medical devices and has a portfolio of more than 2000 patents.

Founded in 1989 in Geneva, Bracco Research – owned by the Milan-based Bracco group – is a company active in the research, development and production of innovative ultrasound contrast products for medical imaging. In 1997, Bracco Imaging Geneva was created as a division of Bracco Imaging S.p.A., one of the world leaders in the field of imaging contrast products. Since 2010, both entities have been part of Bracco Switzerland.

More Stories about Greater Geneva Bern area

HubsGoGlobal is a platform under the PharmaBoardroom brand that focuses on the competitive advantages of the Hub and its value proposition in terms of strategic, operational, financial, talent and lifestyle aspects.

PharmaBoardroom provides industry trends, news and reports from all over the world. This site is for senior professionals who want to understand local and global markets.


Greater Geneva Bern area is an initiative of the cantons of
Bern, Fribourg, Vaud, Neuchâtel, Geneva and Valais.

World Trade Center – Av. de Gratta-Paille 2
PO Box 252
1000 Lausanne 22 – Switzerland


Copyright: All rights reserved. No part of this site maybe reproduced in any form or by any means, whether electronic, mechanical or otherwise including photocopying, recording or any information storage or retrieval system without prior written consent of PharmaBoardroom. While every attempt is made to ensure the accuracy of the information contained in this website, neither PharmaBoardroom nor the authors accept any liabilities for errors and omissions. Opinions expressed in this report are not necessarily those of the authors.

2021 © PharmaBoardroom